Immunological studies have shown inflammatory phenotypes in granulocytes (expressing CD66b) are one of the strongest discriminators between non‐infected and infected individuals as well as between severity status of COVID‐19 patients (Vitte et al., 2020). Here, CEACAM8 is linked to COVID-19.